This is best demonstrated in conditions where genetic mutation in inflammasome components lead to aberrant IL-1 and IL-18 signalling, including familial mediterranean fever, cryopyrin-associated periodic syndrome, and neonatal-onset multisystem inflammatory disease (NOMID) [59]. This evidence concerns the gene IL18 and CINCA syndrome.